• 16 Aug 2012

Mapping The Corporate Genome

New white paper on the global Legal Entity Identifier (LEI) initiative

Caption|REUTERS/Michael DalderThomson Reuters is committed to mapping the "corporate genome" and promoting the evolution of legal entity data for the benefit of forward-looking institutions looking for innovation in risk management and an edge in the marketplace.

A primary aim of the global Legal Entity Identifier (LEI) initiative is to provide market participants with the ability to use a common set of reference data to easily identify legal entities and their associated inter-connections (parent, subsidiary and affiliate) - across multiple platforms/repositories (trading, data, compliance).

Equally, by using LEIs market participants will be able to map those entities back to their associated securities/debt issues thus allowing market players to efficiently correlate their risk exposure to a counterparty at any given moment in time.

In light of this complex market challenge we have published a detailed white paper Legal Entity Data: Mapping The Corporate Genome that provides:

  • an overview of where the LEI initiative now stands and its associated background
  • a comprehensive understanding of what the operational and systems impact of using Legal Entity Data will be
  • an outline of what additional beneficial outcomes market participants can expect from using Legal Entity Data and
  • a better understanding of Thomson Reuters perspective with regard to the LEI initiative and the need for Legal Entity Data
Download a copy of the white paper Legal Entity Data: Mapping The Corporate Genome